Electrophysiological study of V535M hERG mutation of LQT2

Abstract

This study examined the current changes of human ether-a-go-go-related gene (hERG) mutation derived from a LQT2 Chinese family with a highly penetrating phenotype. Mutation was identified and site-directed mutagenesis was performed to induce the mutation in wild-type (WT) hERG. WT hERG and mutated V535M were cloned and transiently expressed in HEK293 cells. At the 48th and 72nd h after transfection, membrane currents were recorded using whole cell patch-clamp procedures. An A>G transition at 1605 resulting in replacement of V535M was identified. Compared to WT, V535M mutation significantly decreased tail currents of hERG. At test potential of −40 mV after depolarizing at +50 mV, tail current densities were 83.35±7.06 pA/pF in WT and 50.38±7.74 pA/pF in V535M respectively (n=20, P<0.01). Gating kinetics of hERG revealed that V_1/2 of steady-state inactivation shifted to negative potential in the mutant (V_1/2,V535M: −61.81±1.7 mV vs. V_{1/2, WT}: −43.1±0.71 mV). The time constant of recovery from inactivation was markedly prolonged in the mutant compared to WT among test potentials. V535M hERG mutation demonstrated markedly decreased tail current densities, which suggests that V535M is a new loss-of-function mutation of hERG channel responsible for LQT2.

Keywords

ion channel / long QT2 syndrome / human ether-a-go-go-related gene current / cardiac arrhythmia

References

[1] AlvarezP.A., PahissaJ.. QT alterations in psychopharmacology: proven candidates and suspects. Curr Drug Saf, 2010, 5(1): 97-104

[2] RhodesT.E., AbrahamR.L., WelchR.C., et al.. Cardiac potassium channel dysfunction in sudden infant death syn drome. J Mol Cell Cardiol, 2008, 44(3): 571-581

[3] WedekindH., BurdeD., ZumhagenS., et al.. QT interval prolongation and risk for cardiac events in genotyped LQTS-index children. Eur J Pediatr, 2009, 168(9): 1107-1115

[4] OhnoS., ZankovD.P., YoshidaH., et al.. N- and C-terminal KCNE1 mutations cause distinct phenotypes of long QT syndrome. Heart Rhythm, 2007, 4(3): 332-340

[5] HedleyP.L., JørgensenP., SchlamowitzS., et al.. The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat, 2009, 30(11): 1486-1511

[6] TengG.Q., ZhaoX., Lees-MillerJ.P., et al.. Homozygous missense N629D hERG (KCNH2) potassium channel mutation causes developmental defects in the right ventricle and its outflow tract and embryonic lethality. Circ Res, 2008, 103(12): 1483-1491

[7] AmorósI., Jiménez-JáimezJ., TercedorL., et al.. Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome. Heart Rhythm, 2011, 8(3): 463-470

[8] SchmalhoferW.A., SwensenA.M., ThomasB.S., et al.. A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel. Assay Drug Dev Technol, 2010, 8(6): 714-726

[9] CrottiL., LundquistA.L., InsoliaR., et al.. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation, 2005, 112(9): 1251-1258

[10] RossenbackerT., MubagwaK., JongbloedR.J., et al.. Novel mutation in the Per-Arnt-Sim domain of KCNH2 causes a malignant form of long-QT syndrome. Circulation, 2005, 111(8): 961-968

[11] BezzinaC.R., VerkerkA.O., BusjahnA., et al.. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res, 2003, 59(1): 27-36

[12] AnsonB.D., AckermanM.J., TesterD.J., et al.. Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels. Am J Physiol Heart Circ Physiol, 2004, 286: H2434-H2441

[13] AminA.S., HerfstL.J., DelisleB.P., et al.. Fever-induced QTc prolongation and ventricular arrhythmias in individuals with type 2 congenital long QT syndrome. J Clin Invest, 2008, 118(7): 2552-2561

[14] NakajimaT., FurukawaT., HiranoY., et al.. Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2. Cardiovasc Res, 1999, 44(2): 283-293

[15] SaenenJ.B., PaulussenA.D., JongbloedR.J., et al.. A single hERG mutation underlying a spectrum of acquired and congenital long QT syndrome phenotypes. J Mol Cell Cardiol, 2007, 43(1): 63-72

[16] PiperD.R., HinzW.A., TallurriC.K., et al.. Regional specificity of human ether-a′-go-go-related gene channel activation and inactivation gating. J Biol Chem, 2005, 280(8): 7206-7217

[17] BähringR., CovarrubiasM.. Mechanisms of closed-state inactivation in voltage-gated ion channels. J Physiol, 2011, 589(Pt3): 461-479

[18] SmithP.L., YellenG.. Fast and slow voltage sensor movements in HERG potassium channels. J Gen Physiol, 2002, 119(3): 275-293

[19] PiperD.R., RuppJ., SachseF.B., et al.. Cooperative interactions between R531 and acidic residues in the voltage sensing module of hERG1 channels. Cell Physiol Biochem, 2008, 21(1–3): 37-46

[20] JonssonM.K., VosM.A., DukerG., et al.. Gender disparity in cardiac electrophysiology: implications for cardiac safety pharmacology. Pharmacol Ther, 2010, 127(1): 9-18

[21] LanfranchiP.A., AckermanM.J., KaraT., et al.. Gene-specific paradoxical QT responses during rapid eye movement sleep in women with congenital long QT syndrome. Heart Rhythm, 2010, 7(8): 1067-1074

[22] TanH.L., BardaiA., ShimizuW., et al.. Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications. Circulation, 2006, 114(20): 2096-2103

[23] GonzalezR., Gomis-TenaJ., CorriasA., et al.. Sex and age related differences in drug induced QT prolongation by dofetilide under reduced repolarization reserve in simulated ventricular cells. Conf Proc IEEE Eng Med Biol Soc, 2010, 2010: 3245-3248

[24] SanguinettiM.C., CurranM.E., SpectorP.S., et al.. Spectrum of HERG K1 channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci USA, 1996, 93: 2208-2212

[25] LiX., XuJ., LiM.. The human D1261 mutation of the HERG potassium channel results in a truncated protein that contains a subunit interaction domain and decreases the channel expression. J Biol Chem, 1997, 272: 705-708

[26] AndersonC.L., DelisleB.P., AnsonB.D., et al.. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation, 2006, 113(3): 365-373

[27] FickerE., DennisA.T., Obejero-PazC.A., et al.. Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome. J Mol Cell Cardiol, 2000, 32(12): 2327-2337

[28] DelisleB.P., AnsonB.D., RajamaniS., et al.. Biology of cardiac arrhythmias: ion channel protein trafficking. Circ Res, 2004, 94(11): 1418-1428